Plant-derived anticancer agents

Area of Science:

• Pharmacology
• Natural Products Chemistry
• Oncology

Background:

• Natural product drugs are crucial in pharmaceutical care, particularly for antitumor therapies like paclitaxel and vincristine.
• Bioactivity-guided fractionation is the primary method for discovering novel natural product drugs with unique mechanisms of action.
• Despite advances, many potential natural product drugs remain undiscovered, highlighting the need for continued exploration.

Purpose of the Study:

• To propose the development of a cancer chemoprevention drug formulation for widespread public use.
• To emphasize the role of natural products as cancer chemopreventive agents capable of inhibiting carcinogenesis.
• To advocate for immediate implementation of such a formulation, considering pharmacoeconomic factors and future improvements.

Main Methods:

• Leveraging bioactivity-guided fractionation for the discovery of novel antitumor natural products.
• Exploring combinatorial chemistry and high throughput screening to accelerate natural product lead identification.
• Analyzing the pharmacoeconomics of a proposed cancer chemoprevention formulation.

Main Results:

• Natural products have historically yielded significant antitumor drugs, demonstrating their therapeutic potential.
• Cancer chemopreventive agents, many derived from natural products, can effectively prevent or inhibit carcinogenesis.
• The proposed formulation aims for broad public health impact against the pandemic nature of cancer.

Conclusions:

• Continued discovery and utilization of natural products are essential for advancing cancer treatment and prevention.
• A proactive approach involving a widely accessible cancer chemoprevention formulation is warranted.
• Immediate implementation of a cancer chemoprevention strategy, with ongoing refinement, is crucial for public health.